Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock–a quality improvement study.
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There is ample literature available on the association between both time to antibiotics and appropriateness of antibiotics and clinical outcomes from sepsis. In fact, the current state of debate surrounds the balance to be struck between prompt empirical therapy and care in the choice of appropriate antibiotics (both in terms of the susceptibility of infecting organism and minimizing resistance arising from use of broad-spectrum agents). The objective of this study is to determine sepsis bundle compliance and the appropriateness of antimicrobial therapy in patients with severe sepsis and septic shock and its impact on outcomes. MATERIAL: This study was conducted in the ICU of a tertiary care, private hospital in São Paulo, Brazil. A retrospective cohort study was conducted from July 2005 to December 2012 in patients with severe sepsis and septic shock. RESULTS: A total of 1,279 patients were identified with severe sepsis and septic shock, of which 358 (32.1%) had bloodstream infection (BSI). The inpatient mortality rate was 29%. In evaluation of the sepsis bundle, over time there was a progressive increase in serum arterial lactate collection, obtaining blood cultures prior to antibiotic administration, administration of broad-spectrum antibiotics within 1 hour, and administration of appropriate antimicrobials, with statistically significant differences in the later years of the study. We also observed a significant decrease in mortality. In patients with bloodstream infection, after adjustment for other covariates the administration of appropriate antimicrobial therapy was associated with a decrease in mortality in patients with severe sepsis and septic shock (p = 0.023). CONCLUSIONS: The administration of appropriate antimicrobial therapy was independently associated with a decline in mortality in patients with severe sepsis and septic shock due to bloodstream infection. As protocol adherence increased over time, the crude mortality rate decreased, which reinforces the need to implement institutional guidelines and monitor appropriate antimicrobial therapy compliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The signs and symptoms of sepsis are nonspecific and often mimic multiple other diseases (90-92).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Limited data from resource-limited settings suggest that timely administration of antimicrobials in patients with sepsis and septic shock is beneficial and potentially feasible [121–126].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [126]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“In the APACHE II study [21], calculations were done only on the day of admission.”
MethodBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958 · cited 1×
“Of the ESKAPE pathogens [19,20], which have paramount importance due to the their pathogenesis, transmission mode and antimicrobial resistance, the most common was E.”
Background
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
The timing of early antibiotics and hospital mortality in sepsis.
Liu, V. X., Fielding-Singh, V., Greene, J. D., Baker, J. M., Iwashyna, T. J., Bhattacharya, J., & Escobar, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1848oc · Cited by 1,006
“Other smaller studies have reported similar findings (14, 17, 18, 28, 29, 31, 32, 43).”
ResultSterling, S. A., Miller, W. R., Pryor, J., Puskarich, M. A., & Jones, A. E. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001142 · Cited by 434
“Significant association with mortality and appropriate antibiotics in 1 hr Gurnani et al (32) ICU TTA and appropriate fluid resuscitation Single center, United States 2006–2007 118 Sepsis recognition 8 Mortality data A sepsis protocol emphasizing early antibiotics and adequate fluids improved clinical outcomes Hitti e…”
InfluentialCulture-Negative Severe Sepsis
Gupta, S., Sakhuja, A., Kumar, G., McGrath, E., Nanchal, R. S., & Kashani, K. B. (2016) · Chest · doi:10.1016/j.chest.2016.08.1460 · Cited by 232
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Tabak, Y. P., Vankeepuram, L., Ye, G., Jeffers, K., Gupta, V., & Murray, P. R. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00500-18 · Cited by 158
Appropriateness of antibiotic prescribing in the Emergency Department
Denny, K. J., Gartside, J., Alcorn, K., Cross, J., Maloney, S., & Keijzers, G. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky447 · Cited by 164
Monard, C., Pehlivan, J., Auger, G., Alviset, S., Tran‐Dinh, A., Duquaire, P., Gastli, N., d’Humières, C., Maamar, A., Boibieux, A., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03114-y · Cited by 144
“Inadequate and delayed empirical treatments are strong predictors of mortality in sepsis [1, 2].”
BackgroundSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Asner, S. A., Desgranges, F., Schrijver, I. T., & Calandra, T. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.03.003 · Cited by 81
Corl, K. A., Zeba, F., Caffrey, A. R., Hermenau, M., Lopes, V., Phillips, G. S., Merchant, R. C., Levy, M. M., & LaPlante, K. L. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004212 · Cited by 62
Door-to-antibiotic time and mortality in patients with sepsis: Systematic review and meta-analysis
Leung, L. Y., Huang, H.-L., Hung, K. K. C., Leung, C. Y., Lam, C., Lo, R. S., Yeung, C. Y., Tsoi, P. J., Lai, M., Brabrand, M., et al. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.06.015 · Cited by 73
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Zhang, J., Yan, W., Dong, Y., Luo, X., Miao, H., Maimaijuma, T., Xu, X., Jiang, H., Huang, Z., Qi, L., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1191 · Cited by 53
“Limited data from resource-limited context suggest that timely administration of antibiotics is beneficial and potentially feasible in patients with sepsis and septic shock (123-128).”
For the sepsis in resource-limited settings–expert consensus recommendations group of the European Society of Intensive Care Medicine (ESICM) and the Mahidol-Oxford Research Unit (MORU) in Bangkok, T., Thwaites, C. L., Lundeg, G., & Dondorp, A. M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4415-3 · Cited by 35
“In resource-limited settings, microbiological laboratory facilities are often restricted, but there was evidence from these settings that taking blood cultures was associated with improved outcome in sepsis and septic shock and with improved appropriateness of antibiotics [2, 6, 7].”
The noncanonical inflammasome-induced pyroptosis and septic shock
Wu, J., Cai, J., Tang, Y., & Lü, B. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101844 · Cited by 37
Clinical factors influencing mortality risk in hospital-acquired sepsis
López-Mestanza, C., Andaluz‐Ojeda, D., Gómez-López, J. R., & Bermejo-Martín, J. F. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.08.022 · Cited by 31
del Castillo, J. M. G., Domínguez-Bernal, C., Gutiérrez-Martín, M. C., Núñez-Orantos, M. J., Candel, F. J., & Martín‐Sánchez, F. J. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.10.005 · Cited by 27
Mirjalili, M., Zand, F., Karimzadeh, I., Masjedi, M., Sabetian, G., Mirzaei, E., & Vazin, A. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154170 · Cited by 28
A Role for Antimicrobial Stewardship in Clinical Sepsis Pathways: a Prospective Interventional Study
Burston, J., Adhikari, S., Hayen, A. D., Doolan, H., Kelly, M. L., Fu, K., Jensen, T. Ø., & Koneçny, P. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.139 · Cited by 26
“Urinary 22 (21) 11 (21) Biliary or gastrointestinal 18 (17) 7 (13) Neutropenic 8 (8) 4 (8)”
Prytz, K. L., Prag, M., Fredlund, H., Magnuson, A., Sundqvist, M., & Källman, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236864 · Cited by 26
Park, S. Y., Lee, E. J., Kim, T., Yu, S. N., Park, K., Lee, M. S., Park, S. Y., Jeon, M. H., Kim, T. H., & Choo, E. J. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.10.018 · Cited by 24
Quality improvement in pediatric sepsis
Melendez, E., & Bachur, R. G. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000222 · Cited by 23
Risk factors and outcomes of afebrile bacteremia patients in an emergency department
Yo, C., Lee, M.-T. G., Hsein, Y.-C., & Lee, C. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.08.020 · Cited by 23
“…therapy (Angus and vander Poll, 2013; Armen et al., 2014; Kramer et al., 2015;Mouncey et al., 2015; Paul et al., 2010; van Zanten, 2014; Yokota et al., 2014) within 24 hour of admission, and even within 1 hour when sepsis was found (Barie et al., 2005; Castellanos-Ortega et al., 2010;…”
BackgroundIndividualized antibiotic strategies
Taccone, F. S., Bond, O., Cavicchi, F. Z., & Hites, M. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000302 · Cited by 22
“In another retrospective study, a total of 1279 patients with severe sepsis and septic shock were identified; of which 32% had bloodstream infections [14].”
BackgroundWang, M., Geng, J.-L., Chen, Y.-J., Song, Y., Sun, M., Liu, H.-Z., & Hu, C.-J. (2016) · Letters in Applied Microbiology · doi:10.1111/lam.12676 · Cited by 18
“The timely administration of appropriate antimicrobial therapy for resistant pathogens was independently associated with a decline in the mortality of patients with severe sepsis and septic shock (Yokota et al. 2014; Cain et al. 2015).”
BackgroundEarly management of adult sepsis and septic shock: Korean clinical practice guidelines
Park, C., Ku, N. S., Park, D. W., Park, J. H., Ha, T. S., Kim, D., Park, S. Y., Chang, Y., Jo, K.-W., Baek, M. S., et al. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00920 · Cited by 21
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Abdul-Aziz, M. H., Driver, E., Lipman, J., & Roberts, J. A. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1484452 · Cited by 15
“Microbiology laboratories may require 48–72 h after microbiological cultures are taken to provide the results and this delay has been associated with devastatingly negative consequences [20,21].”
BackgroundAgreement on the prescription of antimicrobial drugs
Casaroto, E., Marra, A. R., Camargo, T. Z. S., de Souza, A. R. A., de Almeida, C. E. S., Pedroti, E. P., Victor, E. D. S., dos Santos, O. F. P., Edmond, M. B., & Campos, A. H. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0992-y · Cited by 14
Self-citationTime to administration of antibiotics and mortality in sepsis
Siewers, K., Abdullah, S. M. O. B., Sørensen, R. H., & Nielsen, F. E. (2021) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12435 · Cited by 21
Sim, J., Hong, S. S., Kwak, J. Y., & Jung, Y. T. (2020) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-020-01535-6 · Cited by 12
Leitl, C. J., Stoll, S. E., Wetsch, W. A., Kammerer, T., Mathes, A., Böttiger, B. W., Seifert, H., & Dusse, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041466 · Cited by 11
Infection management in patients with sepsis and septic shock in resource-limited settings
Thwaites, L., Lundeg, G., & Dondorp, A. M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4547-5 · Cited by 12
Al-Kader, D. A., Anwar, S., Hussaini, H., Amaowei, E. E. J., Rasuli, S. F., Hussain, N., Kaddo, S., & Memon, A. (2022) · Cureus · doi:10.7759/cureus.32405 · Cited by 13
“In three studies [6,17-42], mortality in patients with septic shock was linked to delays of one hour or more.”
BackgroundInfluentialAl-Ani, A. H. H. D. A., Harun, S. N., Othman, N., Ibrahim, B., Abdulbagi, O. E., Abdullah, I., & Ariffin, I. A. (2023) · Antibiotics · doi:10.3390/antibiotics12081305 · Cited by 9
“, neglecting the patient’s severity of illness can affect the decision to use optimal antimicrobial therapy [30].”
BackgroundEffect of the inadequacy of antibiotic therapy in the Emergency Department on hospital stays
del Castillo, J. M. G., Domínguez-Bernal, C., Gutiérrez-Martín, M. C., Núñez-Orantos, M. J., Candel, F. J., & Martín‐Sánchez, F. J. (2017) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.03.004 · Cited by 9
Kim, M., Song, K., Kim, C.-J., Choe, P. G., Park, W. B., Bang, J. H., Kim, E. S., Park, S., Kim, N. J., Oh, M., et al. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e116 · Cited by 9
Ku, N. S., Lee, Y., & Park, D. W. (2025) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2025.037 · Cited by 12
Tuon, F. F., Zequinão, T., da Silva, M. S., & Silva, K. O. (2024) · Infectious Disease Reports · doi:10.3390/idr16040054 · Cited by 8
Babu, M., Menon, V. P., & Devi, P. U. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i5.17102 · Cited by 7
“Appropriate antibiotic administration on admission to the emergency department has been reported to improve the quality of life and survival among the patients [9, 10].”
BackgroundOh, S., Cho, S., Lee, H., Chang, E. J., Min, S.-H., & Ryu, H. G. (2015) · The Korean Journal of Critical Care Medicine · doi:10.4266/kjccm.2015.30.4.249 · Cited by 7
Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings
Thwaites, L., Lundeg, G., Dondorp, A. M., Adhikari, N. K. J., Nakibuuka, J., Jawa, R. S., Mer, M., Murthy, S., Schultz, M. J., Thien, B. N., et al. (2019) · Springer eBooks · doi:10.1007/978-3-030-03143-5_8 · Cited by 12
Yokota, P. K. O., Marra, A. R., Belucci, T. R., Victor, E. D. S., dos Santos, O. F. P., & Edmond, M. B. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00284 · Cited by 9
“5% of cases in the previous study (10), compared to 18% in the current study with 65% in-hospital mortality.”
BackgroundMethodResultInfluentialSelf-citationdel Arco, A., Olalla, J., de la Torre, J., Blázquez, A., Montiel, N., Prada, J. L., Rivas‐Ruiz, F., García-Alegría, J., & Sánchez, F. F. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2458-x · Cited by 6
“For this reason, it is crucial to implement measures for diagnosis and treatment as soon as possible [4].”
BackgroundAl-Ani, A. H. H. D. A., Othman, N., Hassali, M. A., & Ibrahim, B. (2022) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2022.29.5.3 · Cited by 6
“Besides, cancer patients, poly-microbial infections and higher Acute Physiology and Chronic Health Evaluation (APACHI-II) score were also identified as risk factors of the inadequate EAMT (5, 19, 24, 26, 32).”
BackgroundEmpirical monotherapy with meropenem or combination therapy: the microbiological point of view
Garcinuño, P., Santibáñez, M., Gimeno, L., Sánchez-Bautista, A., Coy, J., Sánchez–Payá, J., Boix, V., Merino, E., Portilla, J., & Rodrı́guez, J. C. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2737-2 · Cited by 6
Worapratya, P., Joraluck, J., Wanjaroenchaisuk, A., & Wuthisuthimethawee, P. (2016) · PubMed · Cited by 6
García-Betancur, J. C., Pallares, C., Restrepo-Arbeláez, N., Cadena, E. D. L., Cornistein, W., Byró, P. S., Ferreira, D. B., Ahumada, R., Valdebenito, N., Chaverri-Murillo, J., et al. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01850-24 · Cited by 8
Kiracofe, B., Doepker, B. A., Riha, H. M., Wilkinson, R., Rozycki, E., Adkins, E. J., Lehman, A., & Patel, M. V. B. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.09.006 · Cited by 4
Early Antimicrobial Therapy for Sepsis: Does Each Hour Really Count?
Guery, B. P., & Calandra, T. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1694970 · Cited by 6
Sepsis Management in Resource-Limited Settings
Arslantaş, M. K., & Özdemir, H. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004536 · Cited by 4
Su, W., Shui, H., & Peng, M.-Y. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.11.001 · Cited by 5
Chen, C.-S., Huang, T.-S., Lee, S. S., Chien, F.-C., Yang, C.-H., Li, S.-S., Hsu, C.-J., Sy, C.-L., & Wu, K.-S. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac522 · Cited by 4
Xu, H., Wu, N., Yu, H., Wang, C., Deng, J., Wang, H., Hua, C., Chen, Y., Chen, X., Zhang, T., et al. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s473227 · Cited by 4
Lamichhane, S., Manandhar, N., Dhakal, S., & Shakya, Y. L. (2018) · Journal of Nepal Health Research Council · doi:10.3126/jnhrc.v16i2.20304 · Cited by 3
Todi, S. K., & Debnath, A. K. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jaypee-journals-10071-24667.226 · Cited by 2
Antimicrobial stewardship programs in sepsis treatment: principles, impact, and future directions
Kim, E. S. (2025) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2025.167 · Cited by 5
“In a Brazilian ICU, a quality improvement initiative emphasizing early and appropriate antimicrobial therapy for patients with severe sepsis and septic shock was associated with increased bundle compliance and a decline in inpatient mortality [58].”
Colorafi, K. J., Ferrell, K., D’Andrea, A., & Colorafi, J. (2019) · mHealth · doi:10.21037/mhealth.2019.09.04 · Cited by 2
“04 compliance, in keeping with the literature (6-10).”
BackgroundPrediction of Outcome of Sepsis at Surgical ICU: A Prospective Multi-Center Prospective Study
Salem, A. M. (2019) · Journal of Anesthesia & Intensive Care Medicine · doi:10.19080/jaicm.2019.08.555743 · Cited by 2
Does the timing of antibiotic administration matter in sepsis?
Peltan, I. D., & Liu, V. X. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00043-2 · Cited by 2
Chatelard, P.-A., Rousseau, N., Parmeland, L., Métral, P., Pariset, C., & Vivier, E. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1192002 · Cited by 1
“Up to 20 or 30% of patients with sepsis are initially treated with inappropriate empirical antibiotic therapy (Yokota et al., 2014), and delayed or inappropriate antibiotic therapy is strongly associated with mortality (Kollef, 2000; Leone et al.”
BackgroundExamining nursing practices for management of sepsis in low income countries: the case of Uganda
Aliga, C. A., Mutyabule, J., Nakate, G. M., & Emelonye, A. U. (2018) · Connect The World of Critical Care Nursing · doi:10.1891/1748-6254.12.1.2 · Cited by 1
“The regular assessment of patients could allow early identification an implement timely treatment for sepsis, thereby decreasing mortality rate as well as the associated cost (Yokota et al., 2014).”
BackgroundLiu, C.-C., Hsieh, W. A., Lai, P., Hu, S., Huang, H., & Bih, Z. L. (2017) · PubMed · doi:10.6705/j.jacme.2017.0704.001 · Cited by 1
Puntawang, P., Chenthanakij, B., Tangsuwanaruk, T., Laohakul, P., Phinyo, P., & Wittayachamnankul, B. (2021) · Research Square · doi:10.21203/rs.3.rs-147703/v1 · Cited by 1
del Castillo, J. M. G., Núñez-Orantos, M. J., Candel, F. J., & Martín‐Sánchez, F. J. (2016) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2016.07.014
Treatment of septic patients : fluids, blood and timing of antibiotics
Cronhjort, M. (2016) · Figshare
del Castillo, J. M. G., Núñez-Orantos, M. J., Candel, F. J., & Martín‐Sánchez, F. J. (2017) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2016.07.003
Factores de riesgo de mortalidad en la sepsis nosocomia
Mestanza, I. C. L. (2017) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/27635 · Cited by 2
“En base a los datos disponibles, se obtuvo que la mediana del pH al diagnóstico fue de 7,4 RIC [6,9-8,6], la de la PCR fue de 186,9 mg/mL RIC [181,9-216,6], la de la PCT fue de 2,2 ng/mL RIC [5,5-13,1] y la del lactato de 20,0 mg/dL RIC [23,329,8], observándose diferencias estadísticamente significativas entre los que…”
BackgroundInfluentialCattamanchi, S., Carlson Lucas, C., Felicity, G., & Anbrasi, E. (2018) · International Journal of Critical Care and Emergency Medicine · doi:10.23937/2474-3674/1510042
Outcome and Management of Sepsis at RozhHalat Emergency Hospital in Erbil –Kurdistan region of Iraq
Ahmad, S. Q., Ismaeel, S. M., Mohammed, D. A., & Ahmed, H. F. (2018) · Kurdistan Journal of Applied Research · doi:10.24017/10.24017/science.2018.2.4
On sepsis - epidemiology, prediction and diagnostics
Mellhammar, L. (2020) · Lund University Publications (Lund University)
Vargas-Zabala, D. L., Cabrera-Velasco, C. E., Lozano-Fernandez, V., Cardeño-Sánchez, J. J., & Vargas‐Uricoechea, H. (2020) · Infectio · doi:10.22354/in.v25i1.907
“Infectio 2021; 25(1): 39-44 Resumen Objetivo.”
BackgroundSepsis - an ED perspective. Sepsis Alert & Biomarkers.
Rosenqvist, M. (2021) · Lund University Publications (Lund University)
Sakulkonkij, P., & Bruminhent, J. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.311
Surviving sepsis: Raising awareness to reduce mortality
Golubović, J. (2023) · AIDASCO Reviews · doi:10.59783/aire.2023.32
Sepsis Management in Low- and Middle-Income Countries: A Systematic ReviewPreprint
Jenson, A., Loevinsohn, G. S., Lukacs, T., Osula, V., Jalbout, N. A., Rao, A., Lorenz, K., Chipendo, P. I., & Hansoti, B. (2024) · Research Square · doi:10.21203/rs.3.rs-3789542/v1
Future of Applied Microbiology in Critical Care
Bishawi, A. A., Alamami, A. A., Omrani, A. S., & Kharma, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4006-2_12
Hamadalneel, Y. B., Ahmed, H. O., Abdalrhman, A. A., & Alamin, M. F. (2025) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v20i1.15663
“In another study, appropriate initial empirical antibiotic therapy was the only independent predictor of outcome ( P -value = 0.023) [3].”
InfluentialWolfe, K. H., Hart, S. A., Curry‐Johnson, S., Khan, A., Booth, G. S., Bowden, R. B., Dupont, W. D., Plummer, W. D., Humphries, R. M., & Wiencek, J. R. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag061
Metadata
- Authors
- Yokota, P. K. O., Marra, A. R., Martino, M. D. V., Victor, E. S., Durão, M. S., Edmond, M. B., & dos Santos, O. F. P.
- Affiliations
- Hospital Israelita Albert Einstein (BR)
- Virginia Commonwealth University (US)
- Corresponding author
- Marra, Alexandre R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-11-06
- Volume
- 9
- Issue
- 11
- Pages
- e104475
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4222820
- OpenAlex
- W1996396973
- Cited by
- 85
- References
- 31
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 8 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 5
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- severe sepsis, septic shock, sepsis bundle compliance, empirical antibiotic therapy, bloodstream infection, in-hospital mortality, protocol adherence, arterial lactate, broad-spectrum antibiotics, antimicrobial resistance
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anti-Infective Agents, Escherichia coli Infections, Female, Humans, Intensive Care Units, Male, Middle Aged, Retrospective Studies, Shock, Septic, Staphylococcal Infections, Streptococcal Infections, Treatment Outcome, Hospital Mortality, Sepsis, Quality Improvement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.